BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

54 related articles for article (PubMed ID: 25430414)

  • 1. The association between coronary slow flow and platelet distribution width among patients with stable angina pectoris.
    Ozyurtlu F; Yavuz V; Cetin N; Acet H; Ayhan E; Isik T
    Postepy Kardiol Interwencyjnej; 2014; 10(3):161-5. PubMed ID: 25489301
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endothelial nitric oxide synthase Asp298Glu (894G/T) gene polymorphism as a possible risk factor for the coronary slow flow phenomenon among Iranians.
    Karimi Y; Sehati F; Sarreshtedari A; Mirzad M; Khalili Y; Kiani R; Taheri Bajgan E; Hosseini Moghadam M; Mehrvarz F; Bakhshandeh H; Parham M; Malakootian M; Sadeghipour P
    BMC Cardiovasc Disord; 2022 Jun; 22(1):300. PubMed ID: 35773625
    [TBL] [Abstract][Full Text] [Related]  

  • 3. miRNA-22 as a Candidate Diagnostic Biomarker for Coronary Slow Flow.
    Chen T; Wang ZY; Li CC
    Cardiol Res Pract; 2020; 2020():7490942. PubMed ID: 32774915
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of ghrelin levels and endothelial functions in patients with coronary slow flow phenomenon.
    Çelik O; Demirci E; Aydın M; Karabag T; Kalçık M
    Interv Med Appl Sci; 2017 Sep; 9(3):154-159. PubMed ID: 29201440
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of urotensin II and atherosclerotic risk factors in patients with slow coronary flow.
    Şatıroğlu Ö; Durakoğlugil ME; Çetin M; Çiçek Y; Erdoğan T; Duman H
    Interv Med Appl Sci; 2016 Dec; 8(4):158-163. PubMed ID: 28180005
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The relationship between coronary slow flow phenomenon and urotensin-II: A prospective and controlled study.
    Zengin H; Erbay AR; Okuyucu A; Alaçam H; Yüksel S; Meriç M; Soylu K; Gedikli Ö; Murat N; Gülel O; Demircan S; Akın F; Yılmaz Ö; Şahin M
    Anatol J Cardiol; 2015 Jun; 15(6):475-9. PubMed ID: 25430414
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The relation between coronary flow rate, plasma endothelin-1 concentrations, and clinical characteristics in patients with normal coronary arteries.
    Celebi H; Catakoglu AB; Kurtoglu H; Sener M; Hanavdelogullari R; Demiroglu C; Aytekin V; Aytekin S
    Cardiovasc Revasc Med; 2008; 9(3):144-8. PubMed ID: 18606377
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship of serum salusin beta levels with coronary slow flow.
    Akyüz A; Aydın F; Alpsoy Ş; Ozkaramanli Gur D; Guzel S
    Anatol J Cardiol; 2019 Sep; 22(4):177-184. PubMed ID: 31584433
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of coronary microvascular function and nitric oxide synthase intron 4a/b polymorphism in patients with coronary slow flow.
    Ekmekci A; Güngör B; Özcan KS; Abaci N; Ilhan E; Ekmekci SS; Kemaloğlu T; Osmonov D; Ustek D; Eren M
    Coron Artery Dis; 2013 Sep; 24(6):461-7. PubMed ID: 23811833
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Documentation of impaired coronary blood flow by TIMI frame count method in patients with atrial fibrillation.
    Luo C; Wu X; Huang Z; Du Z; Hao Y; Hu C; Huang Y; Gao X
    Int J Cardiol; 2013 Aug; 167(4):1176-80. PubMed ID: 22483250
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Coronary blood flow in patients with end-stage renal disease assessed by thrombolysis in myocardial infarction frame count method.
    Sobkowicz B; Tomaszuk-Kazberuk A; Kralisz P; Malyszko J; Kalinowski M; Hryszko T; Sawicki R; Dobrzycki S; Musial WJ
    Nephrol Dial Transplant; 2010 Mar; 25(3):926-30. PubMed ID: 19875377
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of the relationship between arterial blood pressure, aortic stiffness and serum endothelin-1 levels in patients with essential hypertension.
    Nar G; Soylu K; Akcay M; Gulel O; Yuksel S; Meric M; Zengin H; Erbay A; Nar R; Demircan S; Sahin M
    Clin Exp Hypertens; 2013; 35(8):589-94. PubMed ID: 23530911
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.